4 ms·
That's a really silly moral stance to take when you are a producer (and marketer) of opioids which lead to hundreds of over-doses annually. The difference is o
by nxsynonym 9y ago
That's a really silly moral stance to take when you are a producer (and marketer) of opioids which lead to hundreds of over-doses annually.
The difference is one patient wants to end their life willingly to escape pain and suffering, while the other is chasing a high and may/may not have been guided into taking Opioids in the first place.
http://fortune.com/2017/05/15/purdue-johnsonandjohnson-opiod-marketing/ http://fortune.com/2017/05/15/purdue-johnsonandjohnson-opiod...
- btian 9y agoThe news is about execution, not euthanasia. Brand value is important for large companies. If I were the CEO of a pharma company, I want my drugs to be associated with health, not death. I bet bullet companies won't mind at all if prisons buy bullets from them to execute prisoners.